Literature DB >> 4341700

Sequence of spontaneous Epstein-Barr virus activation and selective DNA synthesis in activated cells in the presence of hydroxyurea.

B Hampar, J G Derge, L M Martos, M A Tagamets, M A Burroughs.   

Abstract

The sequence of spontaneous Epstein-Barr virus activation was studied in P3HR-1 carrier cells and in P3HR-1(BrdU) cells made resistant to 5-bromodeoxyuridine. Virus activation was initiated during the normal cell cycle, and recruitment of additional virus-activated cells was prevented by the DNA inhibitors, 1-beta-D-arabinofuranosylcytosine and hydroxyurea. Virus activation was followed by synthesis of the early antigen complex in the absence of additional detectable DNA synthesis. Early antigen synthesis was followed by hydroxyurea-resistant synthesis of new DNA, which in the case of P3HR-1(BrdU) cells was characterized by the appearance of thymidine kinase. The newly synthesized DNA banded in neutral cesium chloride at peaks corresponding to normal human DNA and Epstein-Barr viral DNA. Synthesis of viral antigen was seen only in cells that had undergone hydroxyurea-resistant DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341700      PMCID: PMC426995          DOI: 10.1073/pnas.69.9.2589

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.

Authors:  B Hampar; J G Derge; L M Martos; J L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

2.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

3.  Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells.

Authors:  H Zur Hausen; H Schulte-Holthausen
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Electron microscopy of herpes simplex virus. 3. Effect of hydroxyurea.

Authors:  S Nii; H S Rosenkranz; C Morgan; H M Rose
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

6.  Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera.

Authors:  B Hampar; P Gerber; K C Hsu; L M Martos; J L Walker; R F Sigüenza; G A Wells
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

7.  The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.

Authors:  L Gergely; G Klein; I Ernberg
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

8.  Deoxyribonucleoside incorporation and the role of hydroxyurea in a model lymphocyte system for studying DNA repair in carcinogenesis.

Authors:  M W Lieberman; S Sell; E Farber
Journal:  Cancer Res       Date:  1971-09       Impact factor: 12.701

9.  Effect of hydroxyurea on replication of bacteriophage T4 in Escherichia coli.

Authors:  H R Warner; M D Hobbs
Journal:  J Virol       Date:  1969-03       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  8 in total

1.  Cycloheximide induction of xenotropic type C virus from synchronized mouse cells: metabolic requirements for virus activation.

Authors:  J S Greenberger; S A Aaronson
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines.

Authors:  M Andersson
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

3.  Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.

Authors:  W C Summers; G Klein
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells.

Authors:  B Hampar; A Tanaka; M Nonoyama; J G Derge
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

5.  Sedimentation characteristics of newly synthesized Epstein-Barr viral DNA in superinfected cells.

Authors:  P J Siegel; W Clough; J L Strominger
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

6.  Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.

Authors:  C Shipman; S H Smith; R H Carlson; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

7.  Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.

Authors:  B I Lidin; E W Lamon
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Expression of Epstein-Barr viral capsid, complement fixing, and nuclear antigens in stationary and exponential phase cultures.

Authors:  G Miller; L Heston
Journal:  Yale J Biol Med       Date:  1974
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.